Bottom line
FTXH vs SHSSX: the short answer
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both etfs.
But SHSSX is far broader, holding 155 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
FTXH is cheaper at 0.6% vs 0.86% — a difference of $26 a year per $10,000 invested.
Over five years, FTXH returned +6.5% a year vs +5.9% for SHSSX.
Updated Nov 19, 2026
FTXH vs SHSSX side by side
| FTXH | SHSSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.6% | 0.86% |
| Annual cost per $10k | $60 | $86 |
| 10-yr cost on $10k (prospectus) | — | $1,061 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.0% | +16.3% |
| 5-yr return (annualized) | +6.5% | +5.9% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +18.3% | — |
| Worst quarter | −17.4% | — |
| Net assets (fund) | $36.2M | $5.9B |
| Number of holdings | 51 | 155 |
| Portfolio turnover | 35% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of FTXH's top 25 holdings also appear in SHSSX's top 25.
| Holding | FTXH | SHSSX |
|---|---|---|
| Eli Lilly & Company | 7.77% | 12.29% |
| Abbvie Inc | 7.39% | 3.94% |
| Merck & Company Inc | 7.07% | 4.94% |
| Johnson & Johnson | 6.96% | 8.77% |
| Biogen Inc | 3.84% | 1.21% |
| Vertex Pharmaceuticals Inc | 3.41% | 2.74% |
| Amgen Inc | 3.18% | 3.37% |
| Pfizer Inc | 2.97% | 2.61% |
| Gilead Sciences Inc | 2.89% | 4.19% |
| Regeneron Pharmaceuticals Inc | 2.72% | 0.91% |
Source: SEC Form N-PORT
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between FTXH and SHSSX?
Which is cheaper, FTXH or SHSSX?
Should I own both FTXH and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.